Michael Findlay, MD, Cancer Trials New Zealand - View Disclosure - Contact Me Val Gebski, NHMRC Clinical Trials Centre - View Disclosure - Contact Me Peter Gibbs, Royal Melbourne Hospital - View Disclosure - Contact Me Volker Heinemann, MD, Comprehensive Cancer Center, Ludwig-Maximilian-University of Munich, Germany - View Disclosure - Contact Me Marc Peeters, Antwerp University Hospital - View Disclosure - Contact Me Jens Ricke, University Clinic Magdeburg - View Disclosure - Contact Me Mark van Buskirk, Data Reduction LLC - View Disclosure - Contact Me Guy van Hazel, University of Western Australia - View Disclosure - Contact Me
SRX Price at posting:
$15.74 Sentiment: Buy Disclosure: Held